Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency
暂无分享,去创建一个
[1] M. Svoboda,et al. Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer , 2012, Cancer Immunology, Immunotherapy.
[2] Q. Dou,et al. Advances in the understanding of mechanisms and therapeutic use of bortezomib. , 2011, Discovery medicine.
[3] Jason C. Young,et al. Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90 , 2010, The Journal of experimental medicine.
[4] M. Lieber,et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. , 2009, Cancer cell.
[5] Alberto Martin,et al. AID constrains germinal center size by rendering B cells susceptible to apoptosis. , 2009, Blood.
[6] F. Alt,et al. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development , 2008, The Journal of experimental medicine.
[7] Jianmin Yang,et al. Point Mutation of the Proteasome β5 Subunit Gene Is an Important Mechanism of Bortezomib Resistance in Bortezomib-Selected Variants of Jurkat T Cell Lymphoblastic Lymphoma/Leukemia Line , 2008, Journal of Pharmacology and Experimental Therapeutics.
[8] J. Weill,et al. Proteasomal degradation restricts the nuclear lifespan of AID , 2008 .
[9] J. Cohen,et al. Bortezomib Induces Apoptosis of Epstein-Barr Virus (EBV)-Transformed B Cells and Prolongs Survival of Mice Inoculated with EBV-Transformed B Cells , 2007, Journal of Virology.
[10] L. Pasqualucci,et al. Expression of the AID protein in normal and neoplastic B cells. , 2004, Blood.
[11] Alberto Martin,et al. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas , 2002, Nature.
[12] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[13] R. Smith,et al. Burkitt's lymphoma. , 1986, International journal of pediatric otorhinolaryngology.
[14] L. Pasqualucci,et al. AID is required for germinal center–derived lymphomagenesis , 2008, Nature Genetics.
[15] T. Honjo,et al. Role of AID in tumorigenesis. , 2007, Advances in immunology.